questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Protéines membranaires
Glycoprotéines membranaires
Protéines liées au GPI
Carbonic anhydrase-IV
Carbonic anhydrase-IV : Questions médicales fréquentes
Termes MeSH sélectionnés :
Early Detection of Cancer
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Carbonic anhydrase-IV : Questions médicales les plus fréquentes",
"headline": "Carbonic anhydrase-IV : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Carbonic anhydrase-IV : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-15",
"dateModified": "2025-04-11",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Carbonic anhydrase-IV"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Protéines liées au GPI",
"url": "https://questionsmedicales.fr/mesh/D058851",
"about": {
"@type": "MedicalCondition",
"name": "Protéines liées au GPI",
"code": {
"@type": "MedicalCode",
"code": "D058851",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.550.418"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Carbonic anhydrase-IV",
"alternateName": "Carbonic Anhydrase IV",
"code": {
"@type": "MedicalCode",
"code": "D030741",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Claudiu T Supuran",
"url": "https://questionsmedicales.fr/author/Claudiu%20T%20Supuran",
"affiliation": {
"@type": "Organization",
"name": "Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), Pharmaceutical and Nutraceutical Sciences Section, University of Florence, Via Ugo Schiff 6, 50019 Florence, Italy."
}
},
{
"@type": "Person",
"name": "Andrea Angeli",
"url": "https://questionsmedicales.fr/author/Andrea%20Angeli",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurosciences, Psychology, Drug Research and Child Health, Pharmaceutical and Nutraceutical Section, University of Florence, Sesto Fiorentino, Italy."
}
},
{
"@type": "Person",
"name": "Alessio Nocentini",
"url": "https://questionsmedicales.fr/author/Alessio%20Nocentini",
"affiliation": {
"@type": "Organization",
"name": "Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), Pharmaceutical and Nutraceutical Sciences Section, University of Florence, Via Ugo Schiff 6, 50019 Florence, Italy."
}
},
{
"@type": "Person",
"name": "Clemente Capasso",
"url": "https://questionsmedicales.fr/author/Clemente%20Capasso",
"affiliation": {
"@type": "Organization",
"name": "Istituto di Bioscienze e Biorisorse - Consiglio Nazionale delle Ricerche CNR, Via P: Castellino 111, 80131, Naples, Italy."
}
},
{
"@type": "Person",
"name": "Marta Ferraroni",
"url": "https://questionsmedicales.fr/author/Marta%20Ferraroni",
"affiliation": {
"@type": "Organization",
"name": "University of Florence, Department of Chemistry, via della Lastruccia, 50019 Sesto Fiorentino, Italy."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Modelled mortality benefits of multi-cancer early detection screening in England.",
"datePublished": "2023-04-25",
"url": "https://questionsmedicales.fr/article/37185463",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41416-023-02243-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "Impact of early detection on cancer curability: A modified Delphi panel study.",
"datePublished": "2022-12-21",
"url": "https://questionsmedicales.fr/article/36542647",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0279227"
}
},
{
"@type": "ScholarlyArticle",
"name": "Advances in microRNAs as Emerging Biomarkers for Colorectal Cancer Early Detection and Diagnosis.",
"datePublished": "2024-10-15",
"url": "https://questionsmedicales.fr/article/39456841",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms252011060"
}
},
{
"@type": "ScholarlyArticle",
"name": "REPRESENT recommendations: improving inclusion and trust in cancer early detection research.",
"datePublished": "2023-09-09",
"url": "https://questionsmedicales.fr/article/37689805",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41416-023-02414-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "Evaluation of cell-free DNA approaches for multi-cancer early detection.",
"datePublished": "2022-11-17",
"url": "https://questionsmedicales.fr/article/36400018",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ccell.2022.10.022"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protéines membranaires",
"item": "https://questionsmedicales.fr/mesh/D008565"
},
{
"@type": "ListItem",
"position": 5,
"name": "Glycoprotéines membranaires",
"item": "https://questionsmedicales.fr/mesh/D008562"
},
{
"@type": "ListItem",
"position": 6,
"name": "Protéines liées au GPI",
"item": "https://questionsmedicales.fr/mesh/D058851"
},
{
"@type": "ListItem",
"position": 7,
"name": "Carbonic anhydrase-IV",
"item": "https://questionsmedicales.fr/mesh/D030741"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Carbonic anhydrase-IV - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Carbonic anhydrase-IV",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-10",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Carbonic anhydrase-IV",
"description": "Comment diagnostiquer une déficience en anhydrase carbonique IV ?\nQuels examens sont utilisés pour évaluer l'activité de l'enzyme ?\nQuels symptômes peuvent indiquer un problème avec l'enzyme ?\nY a-t-il des marqueurs biologiques spécifiques ?\nPeut-on utiliser l'imagerie pour le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D030741?mesh_terms=Early+Detection+of+Cancer&page=5#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Carbonic anhydrase-IV",
"description": "Quels sont les symptômes d'une déficience en anhydrase carbonique IV ?\nComment se manifestent les troubles respiratoires ?\nY a-t-il des symptômes neurologiques associés ?\nLes calculs rénaux sont-ils un symptôme courant ?\nPeut-on observer des symptômes digestifs ?",
"url": "https://questionsmedicales.fr/mesh/D030741?mesh_terms=Early+Detection+of+Cancer&page=5#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Carbonic anhydrase-IV",
"description": "Peut-on prévenir la déficience en anhydrase carbonique IV ?\nY a-t-il des mesures préventives pour les calculs rénaux ?\nLes tests génétiques peuvent-ils aider à la prévention ?\nDes conseils diététiques peuvent-ils prévenir les symptômes ?\nLes activités physiques sont-elles bénéfiques ?",
"url": "https://questionsmedicales.fr/mesh/D030741?mesh_terms=Early+Detection+of+Cancer&page=5#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Carbonic anhydrase-IV",
"description": "Quels traitements sont disponibles pour la déficience ?\nLa thérapie génique est-elle une option ?\nComment gérer les symptômes respiratoires ?\nY a-t-il des médicaments spécifiques à éviter ?\nLes changements alimentaires sont-ils recommandés ?",
"url": "https://questionsmedicales.fr/mesh/D030741?mesh_terms=Early+Detection+of+Cancer&page=5#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Carbonic anhydrase-IV",
"description": "Quelles complications peuvent survenir avec cette déficience ?\nLes troubles respiratoires peuvent-ils s'aggraver ?\nY a-t-il un risque accru de déshydratation ?\nLes complications neurologiques sont-elles possibles ?\nComment les complications sont-elles gérées ?",
"url": "https://questionsmedicales.fr/mesh/D030741?mesh_terms=Early+Detection+of+Cancer&page=5#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Carbonic anhydrase-IV",
"description": "Quels sont les facteurs de risque pour cette déficience ?\nL'âge joue-t-il un rôle dans le risque ?\nLes maladies rénales augmentent-elles le risque ?\nY a-t-il des facteurs environnementaux à considérer ?\nLes habitudes alimentaires peuvent-elles affecter le risque ?",
"url": "https://questionsmedicales.fr/mesh/D030741?mesh_terms=Early+Detection+of+Cancer&page=5#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une déficience en anhydrase carbonique IV ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests génétiques et des analyses sanguines peuvent confirmer la déficience."
}
},
{
"@type": "Question",
"name": "Quels examens sont utilisés pour évaluer l'activité de l'enzyme ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests enzymatiques dans des échantillons de sang ou de tissus sont utilisés."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer un problème avec l'enzyme ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la déshydratation, des troubles respiratoires ou des calculs rénaux peuvent survenir."
}
},
{
"@type": "Question",
"name": "Y a-t-il des marqueurs biologiques spécifiques ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des niveaux anormaux de bicarbonate dans le sang peuvent indiquer un dysfonctionnement."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser l'imagerie pour le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'imagerie peut aider à évaluer les complications, mais n'est pas spécifique au diagnostic."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une déficience en anhydrase carbonique IV ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fatigue, déshydratation, et troubles respiratoires."
}
},
{
"@type": "Question",
"name": "Comment se manifestent les troubles respiratoires ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent se manifester par une respiration rapide ou des difficultés à respirer."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes neurologiques associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des maux de tête et des troubles de la concentration peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les calculs rénaux sont-ils un symptôme courant ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la formation de calculs rénaux est fréquente en cas de déficience."
}
},
{
"@type": "Question",
"name": "Peut-on observer des symptômes digestifs ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des nausées et des vomissements peuvent également être présents."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir la déficience en anhydrase carbonique IV ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention est difficile, mais un diagnostic précoce peut aider à gérer les symptômes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des mesures préventives pour les calculs rénaux ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Boire beaucoup d'eau et réduire l'apport en sel peut aider à prévenir les calculs."
}
},
{
"@type": "Question",
"name": "Les tests génétiques peuvent-ils aider à la prévention ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les tests génétiques peuvent identifier les personnes à risque."
}
},
{
"@type": "Question",
"name": "Des conseils diététiques peuvent-ils prévenir les symptômes ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation équilibrée peut réduire les symptômes associés."
}
},
{
"@type": "Question",
"name": "Les activités physiques sont-elles bénéfiques ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une activité physique modérée peut améliorer la santé générale et le bien-être."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour la déficience ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des suppléments de bicarbonate et une hydratation adéquate."
}
},
{
"@type": "Question",
"name": "La thérapie génique est-elle une option ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie génique est en recherche, mais pas encore disponible pour cette condition."
}
},
{
"@type": "Question",
"name": "Comment gérer les symptômes respiratoires ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des bronchodilatateurs peuvent être prescrits pour améliorer la respiration."
}
},
{
"@type": "Question",
"name": "Y a-t-il des médicaments spécifiques à éviter ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains diurétiques peuvent aggraver les symptômes et doivent être évités."
}
},
{
"@type": "Question",
"name": "Les changements alimentaires sont-ils recommandés ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en liquides et faible en sodium est souvent conseillée."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec cette déficience ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme l'acidose métabolique et des troubles rénaux peuvent se produire."
}
},
{
"@type": "Question",
"name": "Les troubles respiratoires peuvent-ils s'aggraver ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, sans traitement, les troubles respiratoires peuvent devenir graves."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque accru de déshydratation ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les patients peuvent être plus susceptibles de souffrir de déshydratation."
}
},
{
"@type": "Question",
"name": "Les complications neurologiques sont-elles possibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des complications neurologiques comme des convulsions peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment les complications sont-elles gérées ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion des complications nécessite un suivi médical régulier et des traitements adaptés."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour cette déficience ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux et certaines mutations génétiques augmentent le risque."
}
},
{
"@type": "Question",
"name": "L'âge joue-t-il un rôle dans le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines formes de déficience peuvent se manifester dès l'enfance."
}
},
{
"@type": "Question",
"name": "Les maladies rénales augmentent-elles le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les maladies rénales préexistantes peuvent exacerber les symptômes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des facteurs environnementaux à considérer ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines expositions environnementales peuvent influencer le risque de déficience."
}
},
{
"@type": "Question",
"name": "Les habitudes alimentaires peuvent-elles affecter le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation déséquilibrée peut contribuer à des complications."
}
}
]
}
]
}
Screening programmes utilising blood-based multi-cancer early detection (MCED) tests, which can detect a shared cancer signal from any site in the body with a single, low false-positive rate, could re...
A natural history ('interception') model of cancer was previously used to characterise potential benefits of MCED screening (based on published performance of an MCED test). We built upon this using a...
Estimated late-stage and mortality reductions were robust to a range of assumptions. With the least favourable dwell (sojourn) time and cfDNA status hazard ratio assumptions, we estimated, among 100,0...
Realising the potential benefits of MCED tests could substantially reduce late-stage cancer diagnoses and mortality....
Expert consensus on the potential benefits of early cancer detection does not exist for most cancer types. We convened 10 practicing oncologists using a RAND/UCLA modified Delphi panel to evaluate whi...
Colorectal cancer (CRC) remains the second most common cause of cancer-related mortality worldwide, necessitating advancements in early detection and innovative treatment strategies. MicroRNAs (miRNAs...
Detecting cancer early is essential to improving cancer outcomes. Minoritized groups remain underrepresented in early detection cancer research, which means that findings and interventions are not gen...
In the Circulating Cell-free Genome Atlas (NCT02889978) substudy 1, we evaluate several approaches for a circulating cell-free DNA (cfDNA)-based multi-cancer early detection (MCED) test by defining cl...
Globally, among all women, the most frequently detected and diagnosed and the most lethal type of cancer is breast cancer (BC). In particular, bone is one of the most frequent distant metastases 24in ...
GSE55715, GSE103357, and GSE146661 gene expression profiling data were downloaded from the GEO database. There was 14 breast cancer with bone metastasis samples and 8 breast cancer tissue samples. GEO...
By GO enrichment analysis, 143 DEGs were enriched in the following GO terms: extracellular structure organization, extracellular matrix organization, leukocyte migration class II protein complex, coll...
2 abnormally expressed hub genes could play a pivotal role in the breast cancer with bone metastasis by affecting bone homeostasis imbalance in the bone microenvironment....
Seemingly normal tissues progressively become populated by mutant clones over time. Most of these clones bear mutations in well-known cancer genes but only rarely do they transform into cancer. This p...
We analyzed recent mutational screens of healthy and cancer-free diseased tissues to compare somatic drivers and the causes of somatic variation across tissues. We then reviewed the mechanisms of clon...
The extent of somatic variation is highly variable across tissues and depends on intrinsic features, such as tissue architecture and turnover, as well as the exposure to endogenous and exogenous insul...
Somatic variation and the factors governing homeostasis of normal tissues should be taken into account when devising strategies for cancer prevention and early detection....
The summary presented herein covers recommendations on the early detection of prostate cancer and provides a framework to facilitate clinical decision-making in the implementation of prostate cancer s...
The systematic review utilized to inform this guideline was conducted by an independent methodological consultant. The systematic review was based on searches in Ovid MEDLINE and Embase and Cochrane D...
The Early Detection of Prostate Cancer Panel developed evidence- and consensus-based guideline statements to provide guidance in prostate cancer screening, initial and repeat biopsy, and biopsy techni...
Prostate-specific antigen (PSA)-based prostate cancer screening in combination with shared decision-making (SDM) is recommended. Current data regarding risk from population-based cohorts provide a bas...
Lung cancer is a major global health concern with a low survival rate, often due to late-stage diagnosis. Liquid biopsy offers a non-invasive approach to cancer detection and monitoring, utilizing var...
The present study is a systematic review of the evaluation of screening programs as a strategy for early detection of oral cancer. The aim of this study was to assess whether screening through visual ...